Press releases

Sachi Bio presents at ISSR&D Conference as it aims to become the first company in the world to test RNA Therapeutics in Space

Sachi Bio presented data on human brain organoids and their treatment with Nanoligomers, to the space community in the ISSR&D conference...

Aug 31, 2023

Sachi Bio has been selected to provide potential scientific and commercialization evidence for use of accelerated aging and...

Jul 31, 2023

Sachi Bio has successfully completed and graduated from the Advanced Therapies program in the 2022-23 cohort by the Creative Destruction...

Jun 30, 2023

Sachi Bio graduates the Endless Frontier Labs, a start-up accelerator program at the NYU Business school

May 30, 2023

Brain delivery of Nanoligomer using systemic administration What if you could deliver RNA therapeutics to the brain for high-precision...

Mar 31, 2023

Sachi Bio has been selected to join the Creative Destruction Labs 2022-2023 cohort alongside 25 ground-breaking companies in the Advanced...

Oct 1, 2022

Sachi Bio wins NIH SBIR award to advance microbiome leads to treat auto-immune diseases. Difficult-to-treat autoimmune diseases that are...

Sep 20, 2022

Sachi Bio has been selected to join the Endless Frontier Labs 2022-2023 cohort alongside 25 ground-breaking companies in the Life...

Sep 15, 2022

Ph: 720-361-2159

3000 Airport Drive, Unit 201,

Erie, CO 80516